PBH Prestige Consumer Healthcare Inc. Common Stock
NYSE · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$45.26
· of 52w range
· above low
· to high
$42.6252w low
$71.0752w high
Market Cap (MRQ)
$2.55B
P/E (TTM)
12.7
EPS (TTM)
$3.57
Revenue (TTM)
$1.10B
your badges
52W Range
$43–$71
Analyst Rating
BUY
Price Target
$68
P/E
12.7
ROE
9.1%
Net Profit Margin
15.6%
Your badge strip is empty — pin a metric anywhere on this page.
PBH Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$45.26
Market Cap (MRQ)
$2.55B
P/E (TTM)
12.7
EPS (TTM)
$3.57
Revenue (TTM)
$1.10B
ROE (TTM)
9.1%
Debt/Equity (MRQ)
1.1
52W Range
$43–$71
PBH Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Prestige Consumer Healthcare Inc. Common Stock Company overview from Wikipedia
Prestige Consumer Healthcare Inc. (formerly Prestige Brands, Inc.) is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.
Among the brands owned by Prestige are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC Powder and Goody's Headache Powder, Pediacare & Little Remedies children's OTC products and Beano (dietary supplement).
The company's CEO and president is Ron Lombardi, who replaced Matthew Mannelly on June 1, 2015.
History
Prestige Brands Holdings, Inc. was established in 1999 to acquire, revitalize, and line extend leading, often neglected but healthy brands that were considered non-core at major consumer products companies. In 2004, MidOcean Partners sold Prestige Brands to GTCR Golder Rauner.
Acquisitions
The company acquired Blacksmith Brands' portfolio of five brands in 2010.
In December 2011, the company agreed to purchase 17 brands from GlaxoSmithKline including BC Powder, Beano, Ecotrin, Fiber Choice, Goody's Powder, Sominex and Tagamet for $660 million.
In 2013, Prestige Brands Holdings, Inc. acquired Care Pharmaceuticals of Bondi Junction, New South Wales, Australia, a privately held marketer and distributor of over-the-counter (OTC) healthcare brands for children and adults.
In 2014, the company purchased Hydralyte in Australia and New Zealand from the Hydration Pharmaceuticals Trust of Victoria, Australia. Hydralyte is the leading oral rehydration product in Australia and New Zealand.
In April 2014, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire Insight Pharmaceuticals Corporation, a marketer and distributor of feminine care and other over-the-counter healthcare products, for $750 million in cash.
In November 2015, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire DenTek Oral Care Inc. (DenTek), a privately held marketer and distributor of oral care products for $225 million in cash.
In December 2016, Prestige Brands Holdings, Inc. agreed to buy C.B. Fleet Co. from private-equity firm Gryphon Investors for about $825 million.
In July 2021, consumer health business assets were acquired from Akorn Operating Company, LLC for $228.9 million adding TheraTears and other products to their brands.
Divestitures
In 2009, Prestige sold its Denorex and Prell brands of shampoo. It has since divested Fiber Choice, PediaCare, New-Skin, and Dermoplast (2016).
In 2018, Prestige sold off their household cleaning supply division.
Products
Prestige Consumer Healthcare owns many over-the counter medicines and products, including:
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
sectorHealthcare
industryPharmaceuticals
employees890
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$1.09B2017-03-31 → 2026-03-31
EPS$3.912017-03-31 → 2026-03-31
Free Cash Flow$246M2017-03-31 → 2026-03-31
Net margin15.6%2017-03-31 → 2026-03-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | PBH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 12.75Y avg ≈5.5 | ≈5.5 | · | · | |
| P/S (TTM) | 2.35Y avg ≈3.3 | ≈3.3 | · | · | |
| P/B (MRQ) | 1.35Y avg ≈2.2 | ≈2.2 | · | · | |
| Price / FCF (TTM) | 10.85Y avg ≈15.4 | ≈15.4 | · | · | |
| Price / Cash Flow (TTM) | 10.25Y avg ≈14.9 | ≈14.9 | · | · | |
| Price / Tangible Book (MRQ) | -1.9 | · | · | · | |
| PEG Ratio | ≈3.4 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | PBH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 53.5%5Y avg ≈55.7% | ≈55.7% | · | · | |
| Operating Margin (TTM) | 26.3%5Y avg ≈23.4% | ≈23.4% | · | · | |
| EBITDA Margin (TTM) | 29.2%5Y avg ≈26.2% | ≈26.2% | · | · | |
| Pretax Margin | 23.6%5Y avg ≈17.8% | ≈17.8% | · | · | |
| Net Profit Margin (TTM) | 15.6%5Y avg ≈13.3% | ≈13.3% | · | · | |
| ROA (TTM) | 4.3%5Y avg ≈4.3% | ≈4.3% | · | · | |
| ROE (TTM) | 9.1%5Y avg ≈8.6% | ≈8.6% | · | · | |
| ROIC | 12.1%5Y avg ≈8.6% | ≈8.6% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | PBH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 1.15Y avg ≈0.8 | ≈0.8 | · | · | |
| Current Ratio (MRQ) | 3.25Y avg ≈3.1 | ≈3.1 | · | · | |
| Quick Ratio | 2.15Y avg ≈1.9 | ≈1.9 | · | · | |
| Long-Term Debt / Equity (MRQ) | 1.05Y avg ≈0.8 | ≈0.8 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | PBH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -4.3%5Y avg ≈3.1% | ≈3.1% | · | · | |
| Revenue CAGR 3Y | -1.2%5Y avg ≈2.1% | ≈2.1% | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | |
| EPS YoY | -8.9%5Y avg ≈6.1% | ≈6.1% | · | · | |
| Net Income YoY | -11.3%5Y avg ≈5.3% | ≈5.3% | · | · | |
| EPS CAGR 3Y | 2.0% | · | · | · | |
| EPS CAGR 5Y | 3.8% | · | · | · | |
| Net Income CAGR 3Y | 1.5% | · | · | · | |
| Net Income CAGR 5Y | 2.9% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | PBH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.35Y avg ≈0.3 | ≈0.3 | · | · | |
| Inventory Turnover | 3.25Y avg ≈3.5 | ≈3.5 | · | · | |
| Receivables Turnover | 5.65Y avg ≈6.8 | ≈6.8 | · | · | |
| Revenue / Employee | ≈$1.2M | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.02%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $0.98 | $0.89 | 10.0% | |
| March 31, 2026 | $1.23 | $1.40 | -12.4% | |
| Dec. 31, 2025 | $1.14 | $1.16 | -1.4% | |
| Sept. 30, 2025 | $1.07 | $0.98 | 9.2% | |
| June 30, 2025 | $0.95 | $1.01 | -6.0% | |
| March 31, 2025 | $1.32 | $1.31 | 0.64% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Cost of Revenue | $493M | $503M | $501M | $502M | $466M | $396M | $411M | $420M | $465M | $382M | $339M | · | |
| Gross Profit | $596M | $634M | $624M | $625M | $621M | $547M | $552M | $556M | $577M | $500M | $467M | $406M | |
| SG&A Expense | $116M | $108M | $106M | $107M | $107M | $83M | $89M | $90M | $85M | $89M | $72M | $81M | |
| Operating Expenses | $286M | $298M | $282M | $648M | $291M | $250M | $261M | $488M | $361M | $295M | $207M | $199M | |
| Operating Income | $309M | $337M | $342M | $-22M | $330M | $297M | $291M | $68M | $215M | $206M | $260M | $208M | |
| Interest Expense | · | $2M | $5M | $4M | · | · | · | · | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | $342.0K | $217.0K | $388.0K | $203.0K | $162.0K | $92.0K | |
| Other Non-op | $-10M | $-5M | $756.0K | $-2M | $-1M | $1M | $-2M | $-476.0K | $392.0K | $-30.0K | · | · | |
| Pretax Income | $257M | $284M | $276M | $-94M | $262M | $204M | $191M | $-38M | $107M | $111M | $157M | $127M | |
| Income Tax | $67M | $70M | $67M | $-12M | $57M | $39M | $49M | $-2M | $-232M | $41M | $57M | $49M | |
| Net Income | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| EPS (Basic) | $3.93 | $4.32 | $4.21 | $-1.65 | $4.09 | $3.28 | $2.81 | $-0.69 | $6.40 | $1.31 | $1.89 | $1.50 | |
| EPS (Diluted) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 | $1.88 | $1.49 | |
| Shares (Basic) | 48,456,000 | 49,697,000 | 49,757,000 | 49,889,000 | 50,259,000 | 50,210,000 | 50,723,000 | 52,068,000 | 53,099,000 | 52,976,000 | 52,754,000 | 52,170,000 | |
| Shares (Diluted) | 48,720,000 | 50,080,000 | 50,178,000 | 49,889,000 | 50,842,000 | 50,605,000 | 51,140,000 | 52,068,000 | 53,526,000 | 53,362,000 | 53,143,000 | 52,670,000 | |
| EBITDA | $341M | $367M | $373M | $10M | $362M | $328M | $320M | $99M | $249M | $231M | $284M | $225M |
Balance Sheet
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $64M | $98M | $46M | $58M | $27M | $32M | $95M | $28M | $33M | $42M | $27M | $21M | |
| Receivables | $192M | $194M | $177M | $167M | $139M | $115M | $151M | $149M | $141M | $137M | $95M | $88M | |
| Inventory | $159M | $148M | $139M | $162M | $120M | $115M | $116M | $120M | $119M | $116M | $91M | $74M | |
| Prepaid Expense | $17M | $8M | $13M | $4M | $6M | $8M | $4M | $5M | $12M | $40M | $25M | $10M | |
| Current Assets | $431M | $448M | $375M | $392M | $293M | $270M | $366M | $301M | $303M | $334M | $249M | $202M | |
| PP&E (Net) | $122M | $75M | $77M | $70M | $71M | $70M | $56M | $51M | $53M | $51M | $16M | $14M | |
| PP&E (Gross) | $211M | $156M | $149M | $137M | $132M | $124M | $102M | $90M | $83M | $71M | $30M | $26M | |
| Accum. Depreciation | $89M | $81M | $72M | $67M | $61M | $54M | $46M | $39M | $30M | $20M | $15M | $12M | |
| Goodwill | $581M | $527M | $528M | $528M | $579M | $578M | $575M | $579M | $620M | $615M | $360M | $291M | |
| Intangibles | $2.30B | $2.30B | $2.32B | $2.34B | $2.70B | $2.48B | $2.48B | $2.51B | $2.78B | $2.90B | $2.32B | $2.13B | |
| Other Non-current Assets | $11M | $3M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $7M | $1M | $1M | |
| Total Assets | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Accounts Payable | $23M | $19M | $39M | $63M | $56M | $46M | $62M | $57M | $61M | $70M | $38M | $46M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $41M | |
| Current Liabilities | $121M | $107M | $117M | $161M | $143M | $122M | $150M | $127M | $123M | $162M | $107M | $99M | |
| Capital Leases | $21M | $23M | $8M | $10M | $16M | $20M | $25M | $0 | · | · | · | · | |
| Deferred Tax | $447M | $420M | $404M | $380M | $445M | $434M | $408M | $400M | $443M | $715M | $470M | $352M | |
| Other Non-current Liabilities | $6M | $5M | $9M | $8M | $7M | $9M | $25M | $20M | $23M | $18M | $3M | $2M | |
| Total Liabilities | $1.61B | $1.57B | $1.66B | $1.91B | $2.09B | $2.07B | $2.34B | $2.35B | $2.58B | $3.09B | $2.20B | $2.01B | |
| Long-term Debt | $994M | $992M | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | · | · | $1.56B | |
| Total Debt | · | · | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | $2.19B | $1.63B | $1.59B | |
| Common Stock | $562.0K | $560.0K | $555.0K | $548.0K | $544.0K | $540.0K | $538.0K | $536.0K | $534.0K | $533.0K | $530.0K | $525.0K | |
| Paid-in Capital | $609M | $593M | $567M | $535M | $516M | $500M | $488M | $479M | $469M | $458M | $445M | $427M | |
| Retained Earnings | $1.75B | $1.56B | $1.34B | $1.13B | $1.21B | $1.01B | $844M | $702M | $736M | $397M | $327M | $227M | |
| Treasury Stock | $439M | $277M | $220M | $189M | $134M | $131M | $118M | $60M | $8M | $7M | $5M | $3M | |
| AOCI | $-28M | $-38M | $-34M | $-32M | $-19M | $-20M | $-44M | $-26M | $-19M | $-26M | $-24M | $-23M | |
| Stockholders' Equity | $1.89B | $1.83B | $1.66B | $1.45B | $1.58B | $1.36B | $1.17B | $1.10B | $1.18B | $823M | $744M | $628M | |
| Liabilities + Equity | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Shares Outstanding | 56,211,000 | 56,010,000 | 55,501,000 | 54,857,000 | 54,430,000 | 53,999,000 | 53,805,000 | 53,670,000 | 53,396,000 | 53,287,000 | 53,066,000 | 52,562,000 |
Cash Flow
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $31M | $30M | $31M | $33M | $32M | $30M | $29M | $32M | $33M | $26M | $24M | $18M | |
| Stock-based Comp | $11M | $11M | $14M | $12M | · | · | · | · | · | $8M | $10M | $7M | |
| Deferred Tax | $23M | $14M | $23M | $-61M | $10M | $19M | $14M | $-41M | $-269M | $-6M | $46M | $29M | |
| Amort. of Intangibles | $18M | $18M | $20M | $22M | $21M | $20M | $20M | $22M | $23M | $20M | $18M | $13M | |
| Other Non-cash | $3M | $-19M | $-14M | $340M | $12M | $22M | $32M | $234M | $106M | $50M | $-5M | $24M | |
| Operating Cash Flow | $258M | $252M | $249M | $230M | $260M | $236M | $217M | $189M | $210M | $149M | $176M | $156M | |
| CapEx | $11M | $8M | $10M | $8M | $10M | $22M | $15M | $10M | $13M | $3M | $4M | $6M | |
| Investing Cash Flow | $-137M | $-17M | $-20M | $-12M | $-257M | $-22M | $-17M | $55M | $-12M | $-695M | $-223M | $-805M | |
| Stock Repurchased | $156M | $52M | $25M | $50M | $0 | $12M | $57M | $50M | $0 | $0 | · | · | |
| Net Stock Activity | $-156M | $-52M | $-25M | $-50M | $0 | $-12M | $-57M | $-50M | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Financing Cash Flow | $-156M | $-182M | $-241M | $-186M | $-8M | $-279M | $-131M | $-249M | $-209M | $561M | $52M | $643M | |
| Net Change in Cash | $-34M | $51M | $-12M | $31M | $-5M | $-62M | $67M | $-5M | $-9M | $15M | $6M | $-7M | |
| Taxes Paid | $46M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $246M | $243M | $239M | $222M | $250M | $213M | $203M | $179M | $198M | $145M | $171M | $150M | |
| Levered FCF | · | $242M | $235M | · | · | · | · | · | · | · | · | · |
Profitability
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% | 58.0% | 57.3% | 56.9% | 55.4% | 56.7% | 58.0% | 56.9% | |
| Operating Margin | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% | 31.5% | 30.2% | 6.9% | 20.7% | 23.3% | 32.3% | 29.1% | |
| Net Margin | 17.5% | 18.9% | 18.6% | -7.3% | 18.9% | 17.5% | 14.8% | -3.7% | 32.6% | 7.9% | 12.4% | 11.0% | |
| Pretax Margin | 23.6% | 25.0% | 24.5% | -8.3% | 24.1% | 21.6% | 19.9% | -3.9% | 10.3% | 12.6% | 19.5% | 17.9% | |
| EBITDA Margin | 31.3% | 32.2% | 33.1% | 0.91% | 33.3% | 34.7% | 33.2% | 10.2% | 23.9% | 26.2% | 35.2% | 31.6% | |
| ROA | 5.5% | 6.4% | 6.3% | -2.3% | 5.8% | 4.7% | 4.1% | -0.99% | 8.8% | 2.0% | 3.6% | 3.5% | |
| ROE | 10.2% | 11.8% | 12.9% | -5.2% | 13.3% | 12.3% | 12.2% | -3.1% | 33.9% | 8.9% | 14.6% | 13.1% | |
| ROIC | 12.1% | 13.9% | 9.3% | -0.70% | 8.5% | 8.5% | 7.5% | 2.2% | 21.6% | 4.3% | 7.0% | 5.8% |
Liquidity & Solvency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 | 2.2 | 2.4 | 2.4 | 2.5 | 2.1 | 2.3 | 2.0 | |
| Quick Ratio | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 | 1.2 | 1.6 | 1.4 | 1.4 | 1.1 | 1.1 | 1.1 | |
| Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| LT Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| Interest Coverage | · | 187.1 | 65.9 | · | · | · | · | · | · | · | · | · |
Efficiency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Inventory Turnover | 3.2 | 3.5 | 3.3 | 3.6 | 4.0 | 3.4 | 3.5 | 3.6 | 4.0 | · | · | · | |
| Receivables Turnover | 5.6 | 6.1 | 6.5 | 7.4 | 8.6 | 7.1 | 6.4 | 6.6 | 7.5 | 7.6 | 8.8 | 9.3 |
Per Share
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $33.58 | $32.76 | $29.82 | $26.38 | $28.98 | $25.15 | $21.76 | $20.42 | $22.07 | $15.44 | $14.03 | $11.94 | |
| Revenue / Share | $22.35 | $22.72 | $22.43 | $22.60 | $21.38 | $18.64 | $18.83 | $18.74 | $19.45 | $16.53 | $15.17 | $13.55 | |
| Cash Flow / Share | $5.29 | $5.02 | $4.96 | $4.60 | $5.11 | $4.66 | $4.25 | $3.64 | $3.93 | $2.77 | $3.28 | $2.97 | |
| Cash / Share | $1.14 | $1.75 | $0.84 | $1.07 | $0.50 | $0.60 | $1.76 | $0.51 | $0.61 | $0.79 | $0.51 | $0.41 | |
| EPS (TTM) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 | $1.88 | $1.49 |
Growth Rates
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -4.3% | 1.1% | -0.21% | 3.8% | 15.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.2% | 1.5% | 6.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.9% | 2.9% | · | · | 24.3% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 2.0% | 8.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -11.3% | 2.5% | · | · | 24.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 1.5% | 8.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Net Income TTM | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| Market Cap | $3.33B | $4.82B | $4.03B | $3.44B | $2.88B | $2.38B | $1.97B | $1.61B | $1.80B | $2.96B | $2.83B | $2.25B | |
| Enterprise Value | · | · | $5.11B | $4.72B | $4.33B | $3.83B | $3.61B | $3.38B | $3.76B | $5.11B | $4.43B | $3.82B | |
| P/E | 15.2 | 20.0 | 17.4 | -38.0 | 13.1 | 13.6 | 13.2 | -43.3 | 5.3 | 42.7 | 28.4 | 28.8 | |
| P/S | 3.1 | 4.2 | 3.6 | 3.0 | 2.7 | 2.5 | 2.0 | 1.6 | 1.7 | 3.4 | 3.5 | 3.2 | |
| P/B | 1.8 | 2.6 | 2.4 | 2.4 | 1.8 | 1.8 | 1.7 | 1.5 | 1.5 | 3.6 | 3.8 | 3.6 | |
| P / Cash Flow | 12.9 | 19.1 | 16.2 | 15.0 | 11.1 | 10.1 | 9.1 | 8.5 | 8.6 | 20.0 | 16.2 | 14.4 | |
| P / FCF | 13.5 | 19.8 | 16.8 | 15.5 | 11.5 | 11.2 | 9.7 | 9.0 | 9.1 | 20.4 | 16.6 | 15.0 | |
| EV / EBITDA | · | · | 13.7 | 462.6 | 12.0 | 11.7 | 11.3 | 34.0 | 15.1 | 22.1 | 15.6 | 17.0 | |
| EV / FCF | · | · | 21.3 | 21.3 | 17.3 | 17.9 | 17.8 | 18.9 | 19.0 | 35.3 | 25.9 | 25.5 | |
| EV / Revenue | · | · | 4.5 | 4.2 | 4.0 | 4.1 | 3.7 | 3.5 | 3.6 | 5.8 | 5.5 | 5.3 | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Earnings Yield | 6.6% | 5.0% | 5.8% | -2.6% | 7.6% | 7.4% | 7.6% | -2.3% | 18.8% | 2.3% | 3.5% | 3.5% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $0 | $0 |
Income Statement
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $266M | $282M | $283M | $274M | $250M | $297M | $290M | $284M | $267M | $277M | $283M | $286M | $279M | $286M | $276M | $289M | |
| Cost of Revenue | $130M | $135M | $126M | $123M | $109M | $127M | $129M | $126M | $121M | $125M | $125M | $126M | $125M | $132M | $125M | $128M | |
| Gross Profit | $136M | $146M | $157M | $152M | $140M | $170M | $161M | $157M | $146M | $152M | $158M | $160M | $155M | $154M | $150M | $161M | |
| SG&A Expense | $43M | $30M | $30M | $28M | $28M | $27M | $26M | $26M | $29M | $26M | $26M | $26M | $28M | $28M | $27M | $26M | |
| Operating Expenses | $84M | $71M | $75M | $72M | $69M | $82M | $69M | $73M | $74M | $70M | $71M | $72M | $69M | $435M | $63M | $77M | |
| Operating Income | $53M | $75M | $82M | $80M | $72M | $88M | $92M | $84M | $72M | $82M | $87M | $88M | $85M | $-281M | $87M | $84M | |
| Other Non-op | $-34.0K | $708.0K | $-10M | $-501.0K | $224.0K | $-4M | $-353.0K | $-395.0K | $-496.0K | $429.0K | $-682.0K | $-229.0K | $1M | $451.0K | $-1M | $-812.0K | |
| Income Tax | $9M | $11M | $15M | $27M | $14M | $24M | $19M | $17M | $9M | $18M | $17M | $17M | $15M | $-59M | $16M | $16M | |
| Net Income | $29M | $54M | $47M | $42M | $47M | $50M | $61M | $54M | $49M | $49M | $53M | $54M | $53M | $-241M | $52M | $51M | |
| EPS (Basic) | $0.61 | $1.13 | $0.98 | $0.86 | $0.96 | $1.01 | $1.23 | $1.10 | $0.98 | $0.99 | $1.07 | $1.08 | $1.07 | $-4.82 | $1.05 | $1.02 | |
| EPS (Diluted) | $0.61 | $1.13 | $0.97 | $0.86 | $0.95 | $1.00 | $1.22 | $1.09 | $0.98 | $0.98 | $1.06 | $1.07 | $1.06 | $-4.80 | $1.04 | $1.02 | |
| Shares (Basic) | 47,462,000 | · | 47,880,000 | 49,025,000 | 49,475,000 | · | 49,597,000 | 49,652,000 | 49,886,000 | · | 49,740,000 | 49,687,000 | 49,767,000 | · | 49,693,000 | 49,804,000 | |
| Shares (Diluted) | 47,604,000 | · | 48,087,000 | 49,264,000 | 49,833,000 | · | 49,993,000 | 49,998,000 | 50,267,000 | · | 50,125,000 | 50,081,000 | 50,196,000 | · | 50,186,000 | 50,265,000 | |
| EBITDA | $61M | · | $82M | $80M | $79M | · | $92M | $84M | $80M | · | $87M | $88M | $93M | · | $87M | $84M |
Balance Sheet
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $64M | $62M | $119M | $140M | $98M | $51M | $52M | $34M | $46M | $64M | $60M | $55M | · | $86M | $42M | |
| Receivables | $187M | $192M | $190M | $199M | $168M | $194M | $167M | $164M | $172M | $177M | $174M | $158M | $158M | · | $157M | $146M | |
| Inventory | $190M | $159M | $164M | $159M | $153M | $148M | $152M | $156M | $152M | $139M | $149M | $161M | $170M | · | $159M | $141M | |
| Prepaid Expense | $30M | $17M | $17M | $20M | $19M | $8M | $8M | $9M | $11M | $13M | $7M | $8M | $9M | · | $7M | $8M | |
| Current Assets | $497M | $431M | $433M | $497M | $481M | $448M | $377M | $381M | $369M | $375M | $394M | $388M | $392M | · | $409M | $337M | |
| PP&E (Net) | $117M | $122M | $128M | $73M | $74M | $75M | $74M | $75M | $75M | $77M | $70M | $71M | $70M | · | $70M | $70M | |
| PP&E (Gross) | · | $211M | · | · | · | $156M | · | · | · | $149M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $89M | · | · | · | $81M | · | · | · | $72M | · | · | · | · | · | · | |
| Goodwill | $651M | $581M | $581M | $528M | $528M | $527M | $527M | $529M | $528M | $528M | $528M | $527M | $527M | $528M | $577M | $576M | |
| Intangibles | $3.24B | $2.30B | $2.30B | $2.29B | $2.29B | $2.30B | $2.31B | $2.32B | $2.32B | $2.32B | $2.33B | $2.33B | $2.34B | · | $2.67B | $2.67B | |
| Other Non-current Assets | $13M | $11M | $4M | $3M | $3M | $3M | $6M | $7M | $6M | $6M | $6M | $4M | $3M | · | $3M | $3M | |
| Total Assets | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Accounts Payable | $37M | $23M | $43M | $42M | $22M | $19M | $20M | $31M | $40M | $39M | $39M | $44M | $58M | · | $64M | $56M | |
| Current Liabilities | $154M | $121M | $140M | $135M | $110M | $107M | $103M | $107M | $114M | $117M | $127M | $130M | $147M | · | $160M | $152M | |
| Capital Leases | $19M | $21M | $18M | $20M | $21M | $23M | $24M | $7M | $7M | $8M | $6M | $7M | $8M | · | $12M | $13M | |
| Deferred Tax | $449M | $447M | $449M | $445M | $427M | $420M | $413M | $415M | $409M | $404M | $397M | $388M | $384M | · | $456M | $443M | |
| Other Non-current Liabilities | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $9M | $9M | $9M | $8M | · | $9M | $9M | |
| Total Liabilities | $2.65B | $1.61B | $1.67B | $1.62B | $1.58B | $1.57B | $1.54B | $1.59B | $1.63B | $1.66B | $1.74B | $1.80B | $1.87B | · | $2.06B | $2.06B | |
| Long-term Debt | $2.02B | $994M | $1.03B | $993M | $993M | $992M | $992M | $1.05B | $1.09B | $1.13B | $1.20B | $1.26B | $1.32B | · | $1.42B | $1.44B | |
| Total Debt | $2.02B | · | · | · | · | · | $1.00B | $1.06B | $1.10B | · | $1.21B | $1.27B | $1.33B | · | $1.44B | $1.46B | |
| Common Stock | $563.0K | $562.0K | $562.0K | $562.0K | $561.0K | $560.0K | $559.0K | $557.0K | $557.0K | $555.0K | $553.0K | $552.0K | $552.0K | · | $548.0K | $547.0K | |
| Paid-in Capital | $613M | $609M | $605M | $603M | $600M | $593M | $588M | $577M | $573M | $567M | $556M | $552M | $547M | · | $533M | $524M | |
| Retained Earnings | $1.78B | $1.75B | $1.69B | $1.65B | $1.60B | $1.56B | $1.51B | $1.44B | $1.39B | $1.34B | $1.29B | $1.24B | $1.19B | · | $1.37B | $1.32B | |
| Treasury Stock | $442M | $439M | $439M | $392M | $316M | $277M | $266M | $263M | $252M | $220M | $220M | $220M | $220M | · | $189M | $189M | |
| AOCI | $-30M | $-28M | $-30M | $-32M | $-32M | $-38M | $-40M | $-27M | $-31M | $-34M | $-29M | $-36M | $-32M | · | $-29M | $-36M | |
| Stockholders' Equity | $1.92B | $1.89B | $1.83B | $1.82B | $1.86B | $1.83B | $1.79B | $1.73B | $1.68B | $1.66B | $1.60B | $1.54B | $1.48B | $1.45B | $1.69B | $1.62B | |
| Liabilities + Equity | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Shares Outstanding | 56,312,000 | 56,211,000 | 56,198,000 | 56,196,000 | 56,171,000 | 56,010,000 | 55,939,000 | 55,769,000 | 55,717,000 | 55,501,000 | 55,329,000 | 55,291,000 | 55,220,000 | 54,857,000 | 54,852,000 | 54,690,000 |
Cash Flow
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Stock-based Comp | $4M | $3M | $3M | $2M | $4M | $3M | $3M | $2M | $3M | $4M | $2M | $4M | $4M | $3M | $2M | $3M | |
| Deferred Tax | $193.0K | $-4M | $4M | $17M | $6M | $7M | $3M | $4M | $612.0K | $8M | $5M | $5M | $4M | $-75M | $10M | $3M | |
| Amort. of Intangibles | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | · | $6M | $6M | |
| Other Non-cash | $29M | · | · | · | $14M | · | · | · | $-6M | · | · | · | $-21M | · | · | · | |
| Operating Cash Flow | $71M | $43M | $78M | $57M | $79M | $62M | $65M | $70M | $55M | $67M | $71M | $62M | $48M | $59M | $55M | $58M | |
| CapEx | $4M | $5M | $3M | $2M | $838.0K | $3M | $2M | $2M | $1M | $3M | $2M | $3M | $1M | $3M | $2M | $2M | |
| Investing Cash Flow | $-1.06B | $-3M | $-129M | $-3M | $-2M | $-3M | $-10M | $-2M | $-2M | $-15M | $-4M | $-3M | $2M | $-6M | $-2M | $-2M | |
| Debt Issued | $1.04B | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $1.04B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $0 | $690.0K | $46M | $75M | $35M | $11M | $2M | $12M | $26M | $0 | $0 | $0 | $25M | $0 | $0 | $12M | |
| Net Stock Activity | $0 | · | · | · | $-35M | · | · | · | $-26M | · | · | · | $-25M | · | · | · | |
| Financing Cash Flow | $1.02B | $-38M | $-7M | $-75M | $-36M | $-11M | $-54M | $-51M | $-66M | $-68M | $-65M | $-54M | $-54M | $-80M | $-10M | $-48M | |
| Net Change in Cash | $25M | $1M | $-57M | $-20M | $42M | $47M | $-666.0K | $17M | $-12M | $-17M | $4M | $5M | $-4M | $-28M | $44M | $7M | |
| Free Cash Flow | $67M | · | · | · | $78M | · | · | · | $54M | · | · | · | $47M | · | · | · |
Profitability
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 51.2% | · | 55.5% | 55.3% | 56.2% | · | 55.5% | 55.5% | 54.7% | · | 55.9% | 55.9% | 55.4% | · | 54.6% | 55.7% | |
| Operating Margin | 19.8% | · | 29.1% | 29.1% | 28.8% | · | 31.7% | 29.7% | 27.0% | · | 30.7% | 30.8% | 30.5% | · | 31.6% | 29.2% | |
| Net Margin | 11.0% | · | 16.5% | 15.4% | 19.0% | · | 21.0% | 19.2% | 18.4% | · | 18.8% | 18.7% | 19.1% | · | 18.9% | 17.6% | |
| EBITDA Margin | 23.1% | · | 29.1% | 29.1% | 31.8% | · | 31.7% | 29.7% | 30.0% | · | 30.7% | 30.8% | 33.2% | · | 31.6% | 29.2% | |
| ROA | 0.73% | · | 1.4% | 1.2% | 1.4% | · | 1.8% | 1.6% | 1.5% | · | 1.5% | 1.5% | 1.5% | · | 1.4% | 1.4% | |
| ROE | 1.6% | · | 2.6% | 2.4% | 2.7% | · | 3.6% | 3.3% | 3.1% | · | 3.2% | 3.4% | 3.5% | · | 3.2% | 3.3% |
Liquidity & Solvency
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | · | 3.1 | 3.7 | 4.4 | · | 3.7 | 3.6 | 3.2 | · | 3.1 | 3.0 | 2.7 | · | 2.6 | 2.2 | |
| Quick Ratio | 1.8 | · | 1.8 | 2.4 | 2.8 | · | 2.1 | 2.0 | 1.8 | · | 1.9 | 1.7 | 1.4 | · | 1.5 | 1.2 | |
| Debt / Equity | 1.1 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 | |
| LT Debt / Equity | 1.0 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 |
Efficiency
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | 0.8 | · | 0.8 | 0.8 | 0.7 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 1.0 | |
| Receivables Turnover | 1.5 | · | 1.6 | 1.5 | 1.5 | · | 1.7 | 1.8 | 1.6 | · | 1.7 | 1.9 | 1.8 | · | 1.9 | 2.0 |
Per Share
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $34.04 | · | $32.55 | $32.48 | $33.03 | · | $31.97 | $31.05 | $30.17 | · | $28.93 | $27.78 | $26.81 | · | $30.75 | $29.62 | |
| Revenue / Share | $5.58 | · | $5.89 | $5.56 | $5.01 | · | $5.81 | $5.68 | $5.31 | · | $5.64 | $5.72 | $5.56 | · | $5.49 | $5.75 | |
| Cash Flow / Share | $1.49 | · | · | · | $1.59 | · | · | · | $1.09 | · | · | · | $0.96 | · | · | · | |
| Cash / Share | $1.58 | · | $1.11 | $2.12 | $2.48 | · | $0.91 | $0.92 | $0.61 | · | $1.15 | $1.09 | $0.99 | · | $1.57 | $0.78 | |
| EPS (TTM) | $3.57 | · | $3.78 | $4.03 | $4.26 | · | $4.27 | $4.11 | $4.09 | · | $-1.61 | $-1.63 | $-1.68 | · | $4.17 | $4.12 |
Valuation (TTM)
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.10B | · | $1.10B | $1.11B | $1.12B | · | $1.12B | $1.11B | $1.11B | · | $1.13B | $1.13B | $1.13B | · | $1.11B | $1.11B | |
| Net Income TTM | $172M | · | $187M | $201M | $213M | · | $214M | $206M | $205M | · | $-81M | $-82M | $-84M | · | $210M | $209M | |
| Market Cap | $2.66B | · | $3.47B | $3.51B | $4.49B | · | $4.37B | $4.02B | $3.84B | · | $3.39B | $3.16B | $3.28B | · | $3.43B | $2.73B | |
| Enterprise Value | $4.59B | · | · | · | · | · | $5.32B | $5.03B | $4.90B | · | $4.53B | $4.38B | $4.56B | · | $4.79B | $4.14B | |
| P/E | 13.2 | · | 16.3 | 15.5 | 18.7 | · | 18.3 | 17.5 | 16.8 | · | -38.0 | -35.1 | -35.4 | · | 15.0 | 12.1 | |
| P/S | 2.4 | · | 3.1 | 3.2 | 4.0 | · | 3.9 | 3.6 | 3.4 | · | 3.0 | 2.8 | 2.9 | · | 3.1 | 2.5 | |
| P/B | 1.4 | · | 1.9 | 1.9 | 2.4 | · | 2.4 | 2.3 | 2.3 | · | 2.1 | 2.1 | 2.2 | · | 2.0 | 1.7 | |
| P / Cash Flow | 37.6 | · | · | · | 56.8 | · | · | · | 70.0 | · | · | · | 68.2 | · | · | · | |
| EV / Revenue | 4.2 | · | · | · | · | · | 4.8 | 4.5 | 4.4 | · | 4.0 | 3.9 | 4.0 | · | 4.3 | 3.7 | |
| Earnings Yield | 7.5% | · | 6.1% | 6.5% | 5.3% | · | 5.5% | 5.7% | 5.9% | · | -2.6% | -2.9% | -2.8% | · | 6.7% | 8.3% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B |
| Gross Margin % | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% |
| Operating Margin % | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% |
| Net Income | $190M | $215M | $209M | $-82M | $205M |
| Diluted EPS | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 |
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Debt / Equity | · | · | 0.7 | 0.9 | 0.9 |
| Current Ratio | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 |
| Quick Ratio | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 |
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $246M | $243M | $239M | $222M | $250M |
Institutional owners (13F) 341 filers · $2.9B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
341
Value held
$2.9B
New positions
39
Exited positions
69
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 39 (-19 vs prior Q) | 69 (+29 vs prior Q) | 108 (-17 vs prior Q) | 119 (-10 vs prior Q) | +2.2M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $370,187,111 | 7,831,333 | 12.99% | Shares |
| VANGUARD GROUP INC | $332,432,481 | 5,388,758 | 11.66% | Shares |
| ARIEL INVESTMENTS, LLC | $230,143,970 | 4,868,711 | 8.07% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $133,553,822 | 2,825,340 | 4.69% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $125,802,061 | 2,661,291 | 4.41% | Shares |
| FULLER & THALER ASSET MANAGEMENT, INC. | $110,225,175 | 2,331,821 | 3.87% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $101,013,343 | 2,136,944 | 3.54% | Shares |
| STATE STREET CORP | $100,047,570 | 2,116,513 | 3.51% | Shares |
| BRANDES INVESTMENT PARTNERS, LP | $96,953,606 | 2,051,060 | 3.40% | Shares |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $88,490,528 | 1,872,023 | 3.10% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $74,306,032 | 1,571,742 | 2.61% | Shares |
| Allspring Global Investments Holdings, LLC | $61,257,112 | 1,271,950 | 2.15% | Shares |
| MORGAN STANLEY | $58,800,671 | 1,243,931 | 2.06% | Shares |
| NORDEA INVESTMENT MANAGEMENT AB | $39,252,108 | 828,628 | 1.38% | Shares |
| NORTHERN TRUST CORP | $36,560,934 | 773,449 | 1.28% | Shares |
| WESTWOOD HOLDINGS GROUP INC | $35,473,535 | 750,445 | 1.24% | Shares |
| RICE HALL JAMES & ASSOCIATES, LLC | $32,601,741 | 689,692 | 1.14% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $31,134,811 | 658,659 | 1.09% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30,922,805 | 654,174 | 1.08% | Shares |
| UBS Group AG | $30,186,858 | 638,605 | 1.06% | Shares |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $29,772,348 | 629,836 | 1.04% | Shares |
| Boston Trust Walden Corp | $28,832,289 | 609,949 | 1.01% | Shares |
| GOLDMAN SACHS GROUP INC | $27,725,541 | 586,536 | 0.97% | Shares |
| CITADEL ADVISORS LLC | $26,667,701 | 564,157 | 0.94% | Shares |
| BANK OF AMERICA CORP /DE/ | $26,277,109 | 555,894 | 0.92% | Shares |
| RAYMOND JAMES FINANCIAL INC | $21,949,967 | 464,353 | 0.77% | Shares |
| Leeward Investments, LLC - MA | $20,700,289 | 437,916 | 0.73% | Shares |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $19,921,578 | 421,440 | 0.70% | Shares |
| Invesco Ltd. | $19,209,111 | 406,370 | 0.67% | Shares |
| Woodline Partners LP | $17,004,012 | 359,721 | 0.60% | Shares |
| ARMISTICE CAPITAL, LLC | $15,882,720 | 336,000 | 0.56% | Shares |
| Glenmede Investment Management, LP | $15,685,425 | 251,369 | 0.55% | Shares |
| Bank of New York Mellon Corp | $15,375,752 | 325,275 | 0.54% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $14,837,438 | 313,887 | 0.52% | Shares |
| D. E. Shaw & Co., Inc. | $14,832,286 | 313,778 | 0.52% | Shares |
| WELLS FARGO & COMPANY/MN | $14,604,614 | 308,962 | 0.51% | Shares |
| Nuveen, LLC | $14,012,435 | 296,434 | 0.49% | Shares |
| Congress Wealth Management LLC / DE / | $13,030,320 | 163,185 | 0.46% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $12,700,693 | 268,684 | 0.45% | Shares |
| Tributary Capital Management, LLC | $11,958,554 | 252,984 | 0.42% | Shares |
| Fisher Asset Management, LLC | $11,698,136 | 247,474 | 0.41% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $11,013,816 | 232,998 | 0.39% | Shares |
| PRUDENTIAL FINANCIAL INC | $10,251,209 | 216,865 | 0.36% | Shares |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $10,122,871 | 214,150 | 0.36% | Shares |
| JPMORGAN CHASE & CO | $10,050,950 | 207,249 | 0.35% | Shares |
| Aristotle Capital Boston, LLC | $10,043,458 | 212,470 | 0.35% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $9,983,703 | 211,206 | 0.35% | Shares |
| FMR LLC | $9,951,172 | 210,518 | 0.35% | Shares |
| GLENMEDE TRUST CO NA | $9,729,017 | 205,818 | 0.34% | Shares |
| JENNISON ASSOCIATES LLC | $9,393,259 | 198,715 | 0.33% | Shares |
Company insiders 50 insiders · 29 officers · 18 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Ronald M. Lombardi | Chief Executive Officer | May 7, 2026 F | 373,465 | 0 | 0 | $0 |
| Matthew Mannelly | President and CEO | June 1, 2015 M | 27,706 | 0 | 0 | $0 |
| Mark Pettie | Chairman and CEO | March 3, 2009 P | 177,168 | 0 | 0 | $0 |
| Frank Palantoni | CEO and President | May 19, 2006 P | 33,278 | 0 | 0 | $0 |
| Christine Sacco | CFO & COO | May 2, 2026 F | 57,374 | 0 | 0 | $0 |
| David S Marberger | Chief Financial Officer | May 9, 2016 A | 11,050 | 0 | 0 | $0 |
| Peter Anderson | Chief Financial Officer | May 25, 2010 D | 401,850 | 0 | 0 | $0 |
| Jeffrey Zerillo | Senior VP Operations | May 11, 2026 S | 41,810 | 0 | 7 | $-246,374 |
| Adel Mekhail | EVP, Marketing & Sales | May 7, 2026 F | 25,703 | 0 | 0 | $0 |
| William P'Pool | SVP, General Counsel & Corp Secretary | May 4, 2026 A | 28,149 | 0 | 0 | $0 |
| Jose Luis Rosado | SVP-Quality & Regulatory Affairs | Jan. 6, 2026 A | 3,436 | 0 | 0 | $0 |
| Mary Beth Fritz | SVP Quality & Regulatory | May 7, 2025 F | 17,051 | 0 | 0 | $0 |
| Timothy Connors | EVP, Sales & Marketing | May 9, 2019 F | 21,717 | 0 | 0 | $0 |
| Jean A Boyko | SVP, Science and Technology | May 15, 2018 M | 11,081 | 0 | 0 | $0 |
| Christopher Heye | Senior Vice President-Canada, Women's Health and Strategic Planning. | May 7, 2018 A | 8,150 | 0 | 0 | $0 |
| Thomas Hochuli | Vice President, Operations | Aug. 14, 2017 F | 6,678 | 0 | 0 | $0 |
| John Parkinson | Senior VP- International | May 12, 2017 F | 62,075 | 0 | 0 | $0 |
| Paul Migaki | VP of Strategic Planning/Canada | May 27, 2016 M | 55,927 | 0 | 0 | $0 |
| Samuel C Cowley | General Counsel and VP | May 27, 2016 M | 32,176 | 0 | 0 | $0 |
| Paul A. Hennessey | Vice President, Operations | May 21, 2014 M | 15,282 | 0 | 0 | $0 |
| Eric S. Klee | Secretary and General Counsel | May 30, 2011 F | 13,236 | 0 | 0 | $0 |
| David Talbert | Senior Vice President, Sales | May 25, 2010 D | 28,331 | 0 | 0 | $0 |
| Lieven Nuyttens | Senior VP, Operations | May 25, 2010 D | 16,640 | 0 | 0 | $0 |
| Charles Jolly | Secretary and General Counsel | March 31, 2009 D | 30,579 | 0 | 0 | $0 |
| Charles Schrank | Chief Mktg. Officer/Household | March 31, 2009 D | 90,846 | 0 | 0 | $0 |
| James E Kelly | SVP - Chief Marketing Officer | May 30, 2008 A | 27,427 | 0 | 0 | $0 |
| Gerard Butler | Chief Sales Officer | Jan. 2, 2007 D | 289,172 | 0 | 0 | $0 |
| Michael Fink | Senior V.P. of Marketing | Feb. 15, 2005 S | 180,560 | 0 | 0 | $0 |
| Eric Millar | Senior V.P. of Operations | Feb. 15, 2005 S | 72,347 | 0 | 0 | $0 |
| Sheila Hopkins | Director | Aug. 5, 2025 A | 30,123 | 0 | 0 | $0 |
| Natale S Ricciardi | Director | Aug. 1, 2023 A | 27,098 | 0 | 0 | $0 |
| COUGHLIN CHRISTOPHER J | Director | Aug. 2, 2022 A | 13,218 | 0 | 0 | $0 |
| James M Jenness | Director | Aug. 4, 2020 A | 22,791 | 0 | 0 | $0 |
| Carl J Johnson | Director | July 31, 2018 A | 14,598 | 0 | 0 | $0 |
| Charles Hinkaty | Director | Aug. 4, 2015 A | 31,714 | 0 | 0 | $0 |
| Patrick Lonergan | Director | Dec. 10, 2012 G | 37,323 | 0 | 0 | $0 |
| John Byom | Director | Aug. 3, 2010 A | 29,755 | 0 | 0 | $0 |
| Vincent J Hemmer | Director | Sept. 10, 2009 J | 80,410 | 0 | 0 | $0 |
| Peter Mann | Director | Aug. 4, 2009 A | 447,700 | 0 | 0 | $0 |
| Dick L Buell | Director | Aug. 4, 2009 A | 27,662 | 0 | 0 | $0 |
| David Donnini | Director | May 29, 2009 S | 0 | 0 | 0 | $0 |
| Ronald B Gordon | Director | Aug. 5, 2008 A | 30,352 | 0 | 0 | $0 |
| Raymond Silcock | Director | Aug. 5, 2008 A | 16,249 | 0 | 0 | $0 |
| John F. Kelly | · | Aug. 4, 2026 A | 7,832 | 0 | 0 | $0 |
| James Darecca | · | Aug. 4, 2026 A | 9,572 | 0 | 0 | $0 |
| Dawn M. Zier | · | Aug. 4, 2026 A | 19,514 | 0 | 0 | $0 |
| Celeste A. Clark | · | Aug. 4, 2026 A | 16,511 | 0 | 0 | $0 |
| John E Byom | · | Aug. 4, 2026 A | 54,575 | 0 | 1 | $-178,050 |
| COSTLEY GARY E | · | Aug. 4, 2020 A | 50,200 | 0 | 0 | $0 |
| GTCR GOLDER RAUNER II LLC | · | May 29, 2009 S | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 67 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 2.86% | 347,516 SH | Oct. 1, 2026 | Daily |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1.17% | 45,519 SH | Oct. 1, 2026 | Daily |
| PILL · Direxion Shares ETF Trust | 1.16% | 4,781 NS | July 31, 2026 | N-PORT |
| HSMV · First Trust Exchange-Traded Fund III | 0.80% | 5,597 NS | July 31, 2026 | N-PORT |
| FYT · First Trust Exchange-Traded AlphaDE… | 0.65% | 25,280 NS | July 31, 2026 | N-PORT |
| SCOW · Pacer Funds Trust | 0.59% | 201 NS | July 31, 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0.52% | 3,105 NS | July 31, 2026 | N-PORT |
| IHE · iShares Trust | 0.51% | 175,342 SH | Sept. 11, 2026 | Daily |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.34% | 92,272 NS | July 31, 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0.25% | 181,211 NS | July 31, 2026 | N-PORT |
| VIOV · VANGUARD ADMIRAL FUNDS | 0.24% | 100,520 SH | Aug. 19, 2026 | Daily |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0.16% | 18,534 NS | July 31, 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.15% | 41,965 SH | Aug. 19, 2026 | Daily |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0.15% | 7,601 SH | Oct. 1, 2026 | Daily |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.13% | 4,372 NS | July 31, 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.12% | 165,811 SH | Aug. 19, 2026 | Daily |
| ROSC · Lattice Strategies Trust | 0.12% | 1,466 NS | July 31, 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.12% | 195,077 NS | July 31, 2026 | N-PORT |
| PDN · Invesco Exchange-Traded Fund Trust … | 0.12% | 8,140 SH | Oct. 1, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.12% | 67,943 SH | Oct. 1, 2026 | Daily |
| EBIT · Harbor ETF Trust | 0.11% | 258 NS | July 31, 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.10% | 1,747 NS | July 31, 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.09% | 43,685 NS | July 31, 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.09% | 11,789 NS | July 31, 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 0.08% | 7,246 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.08% | 22,923 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.07% | 1,227,360 SH | Sept. 11, 2026 | Daily |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.07% | 175,325 SH | Aug. 19, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.07% | 275,721 SH | Aug. 19, 2026 | Daily |
| DFAT · Dimensional ETF Trust | 0.07% | 196,959 NS | July 31, 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.07% | 28,729 SH | Oct. 1, 2026 | Daily |
| VBR · VANGUARD INDEX FUNDS | 0.05% | 690,582 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.05% | 152,317 NS | July 31, 2026 | N-PORT |
| IGRO · iShares Trust | 0.05% | 10,967 SH | Sept. 11, 2026 | Daily |
| WSML · iShares Trust | 0.04% | 5,420 SH | Sept. 11, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.03% | 22,700 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 544,134 SH | Aug. 19, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.03% | 1,087,231 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.03% | 142,413 SH | Aug. 19, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.01% | 117,382 NS | July 31, 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.01% | 36,640 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.01% | 5,233 NS | July 31, 2026 | N-PORT |
| VXUS · VANGUARD STAR FUNDS | 0.01% | 688,472 SH | Aug. 19, 2026 | Daily |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.01% | 453,610 SH | Aug. 19, 2026 | Daily |
| VSGX · VANGUARD WORLD FUND | 0.01% | 9,203 SH | Aug. 19, 2026 | Daily |
| IDEV · iShares Trust | 0.01% | 52,014 SH | Sept. 11, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.01% | 829 NS | July 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 3,004 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 4,442 NS | July 31, 2026 | N-PORT |
| IXUS · iShares Trust | 0.01% | 56,667 SH | Sept. 11, 2026 | Daily |
| ITOT · iShares Trust | 0.00% | 69,137 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 14,019 SH | Sept. 11, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.00% | 6,651 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 10,940 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,510,012 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 69,368 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 4,089 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.00% | 10,506 SH | Aug. 19, 2026 | Daily |
| IJR · iShares Trust | · | 2,889,316 SH | Sept. 10, 2026 | Daily |
| IJS · iShares Trust | · | 422,466 SH | Sept. 8, 2026 | Daily |
| IWN · iShares Trust | · | 449,434 SH | Sept. 11, 2026 | Daily |
| XJR · iShares Trust | · | 6,541 SH | Aug. 31, 2026 | Daily |
| SVAL · iShares Trust | · | 10,792 SH | Sept. 3, 2026 | Daily |
| ISCB · iShares Trust | · | 1,977 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 9,565 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 38,488 SH | Sept. 11, 2026 | Daily |
| SMMV · iShares Trust | · | 20,132 SH | Aug. 25, 2026 | Daily |
PBH Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 10 analysts
BUY
Median target
$70.00
+54.7%
3 30.0%
Strong Buy
4 40.0%
Buy
3 30.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
5 analysts · 2026-10-03Mean target $67.80 +49.8%
← Below all targets
Current price $45.26
Low$55.00
Mean$67.80
High$75.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| TRLV | · | · | -0.45% | -10.3% | -10.4% | 60.2% |
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026